Am I missing something. Wouldn't this quote from Gerber's talk mean that as of today (Sept 7 or nearby) that MOS has not been reached. Aren't we at least 4 months from the date of the May 21 when the control arm MOS was reported to be less than 6 months (although I am thinking the MOS from control arm was reached prior to the date). So, we should be at a minimum of 9.4 months and my guess is at least 12 months. it would be nice to see what percentage of Bavi arms are still alive currently.
Importantly, though median OS has not yet been reached in either bavituximab-containing cohort, there is a clear and persistent separation of the survival curves warranting further development of bavituximab.